BMC cancer
Risk signals and clinical characteristics of serious adverse events of neutropenia associated with pembrolizumab: a FAERS database study.
Jianhui Niu, Shanshan Xu
Published: 202610.1186/s12885-026-15630-1
No abstract available for this study.